Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pulmonary Hypoplasia: later-stage trial registry
4 of 5 indexed Pulmonary Hypoplasia trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Pulmonary Hypoplasia: 5 US clinical trials tracked, 4 recruiting.
Pulmonary Hypoplasia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital Medical Center, Cincinnati, running 2 of these trials.
Enrollment posture brief
Registry condition pulmonary-hypoplasia
OPEN 4 | RECR 80% | LATE 1 | EARLY 0 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)
Pulmonary Hypoplasia lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pulmonary Hypoplasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pulmonary Hypoplasia is recruiting above its size-band peers.
4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pulmonary Hypoplasia research.
Children's Hospital Medical Center, Cincinnati accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Pulmonary Hypoplasia trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Pulmonary Hypoplasia research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Safety and Efficacy of FETO in CDH: A Phase III Trial
Holly L Hedrick, MD
NCT06884423
Safety and Efficacy of FETO in CDH Phase III
Children's Hospital Medical Center, Cincinnati
NCT07187206
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
Children's Hospital Medical Center, Cincinnati
NCT02986087
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
Rodrigo Ruano
NCT03138863
Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia
Children's Hospital of Philadelphia
NCT02549820
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pulmonary Hypoplasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pulmonary Hypoplasia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pulmonary Hypoplasia page
5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Pulmonary Hypoplasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Hospital Medical Center, Cincinnati sponsors the most Pulmonary Hypoplasia trials on record, review their full trial history before evaluating a specific study. See Children's Hospital Medical Center, Cincinnati's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pulmonary Hypoplasia condition card totals 5 registered trials; most-linked intervention GoldBAL2 Detachable Balloon and BALTACCIBDPE100 Delivery Catheter; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.